Genmab — Oktober 2017
-
Nyt om dara i solide kommer 1. halvår 2018
-
God morgen.

-
Celgenes nedtur blev igangsat af skuffende salgstal for psoriasismidlet Otezla, der tvang selskabet til at sænke sin langsigtede salgsprognose. Desuden blev bioteksektoren ifølge Reuters ramt af en nyhed om, at onlineforhandleren Amazon i flere stater er på vej ind i medicinsalg, hvilket kan presse priserne ned.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind

)